When was Solarea Bio's last funding round?

Solarea Bio's most recent recorded round was Early Stage VC in Nov 2025, raising $9.9M.

PrivateMarketView

How much has Solarea Bio raised?

$37.4Macross 4 recorded rounds · Sep 2020 – Nov 2025

Most recently, Solarea Bio raised $9.9M in its Early Stage VC (Nov 2025).

Free account

More of Solarea Bio with a free account

No card required

Membership and data by Private Market View

4 rounds

Nov 2025Early Stage VC$9.9MSEC filing▮

5 investors participated

Aug 2024Seed Round$1.0MSEC filing▮

1 investors participated

May 2023Later Stage VC (Series B)$15.0M▮

+ 1 more investors · free account

Sep 2020Early Stage VC (Series A)$11.3M▮

+ 1 more investors · free account

Solarea Bio has raised $37.4 million across 4 recorded rounds since 2020. The largest was a $9.9 million early-stage round in Nov 2025.

Solarea Bio has filed 4 Form Ds with the SEC since 2020, most recently in Nov 2025 ($9.9 million sold to 5 investors).

12 investors are on record for Solarea Bio, including Viking Global Investors, Joyance Partners, Olive Tree Capital and S2G Investments. By type, the record holds 6 venture capital firms, 1 family office and 1 asset manager. The early-stage round in Nov 2025 drew 5 investors.

For fundraisers

Raising for a company like Solarea Bio?

12 investors have backed Solarea Bio — start your target list with the firms already writing checks in drug discovery.

How much has Solarea Bio raised?: Solarea Bio has raised $37.4M in total across 4 recorded funding rounds.
When was Solarea Bio's last funding round?: Solarea Bio's most recent recorded round was Early Stage VC in Nov 2025, raising $9.9M.